Core-shell nanocapsules were prepared by a modified nanoprecipitation method.
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Organic solvent was then evaporated under vacuum at 40 °C for 30 min to obtain nanocapsule dispersion at the final desired volume 10 mL. Nanocapsules were recovered by centrifugation at 3500 rpm at room temperature for 15 min. Preformulation studies were performed to determine the effect of formulation parameters such as oil concentration, ratio of organic to aqueous phase and CD concentration on nanoparticle characteristics such as mean diameter, polydispersity and zeta potential. According to the pre-formulation results, optimum formulation parameters were selected and CPT (95% HPLC powder, MW: 348.35 g/mole, Sigma-Aldrich) loaded nanocapsules were prepared with the same parameters dissolving CPT (10% w/w of the polymer) in organic phase. To obtain positively charged nanocapsules 0.025% w/v of Protasan™ (MW < 200 kDa, Novamatrix) was added to aqueous phase.
Physicochemical characterization of CPT loaded NCs
Particle size and zeta potential Mean particle size and polydispersity index (PDI) of the CPT-loaded CD nanocapsules were determined by dynamic light scattering (DLS) (Malvern Zetasizer Nano ZS series, UK) at a scattering angle of 173°. Zeta potential of nanocapsules was measured in mV with Malvern Zetasizer Nano ZS at an angle of 12° and 25 °C.
Each measurement was carried out in triplicate.
Imaging of nanocapsules
The morphology of nanocapsules was determined by using Scanning Electron Microscope (FEI Nova™ Nano SEM 430, ABD). Samples were mounted on the metal S3 stubs and coated with 100 Å thick layer of a Gold-Palladium alloy. Then the particles were imaged at 5 to 20 kV.
Determination of CPT content in nanocapsules
Content of CPT in the nanocapsules was quantified by a previously validated HPLC method equipped with a fluorescence detector at an emission wavelength (λ em ) of 435 nm and at an excitation wavelength (λ ex ) of 370 nm. (Agilent 1100, Germany).
Briefly, after the separation of unbound drug by centrifugation at 3500 rpm for 15 min, supernatant was separated and freeze-dried in order to obtain drug loaded nanoparticle in powder form. Resulting powder containing CPT loaded nanocapsules (1 mg) was dissolved in 2 mL of a mixture of DCM and DMSO. The experimental CPT loading was quantified using the peak area of each NC formulation.
Associated Drug (%) and Entrapped Drug Quantity (µg/mL) were calculated as follows; [1] .
Associated Drug (%)= Experimental Drug Loading Theoretical Drug Loading x 100 (1)
In vitro release studies of CPT from nanocapsules
Release behaviour of CPT from nanocapsules was carried out at 37 °C with dialysis membrane (Cellulose Membrane MW: 100,000 Da, Sigma Chemicals., USA)
technique under sink conditions. 2 mL of nanocapsule dispersion was put up in a S4 dialysis bag. The bag containing the nanocapsule suspension was placed in 50 mL of phosphate buffer solution (PBS) containing 0.1% (v/v) Tween 80 at pH 7.4 and pH 1.2 to mimic the physiological conditions. The system was placed in a shaking water bath at 37 °C with an agitation speed of 100 rpm. At specific time periods (0,5., 1., 1,5., 2., 6., 24., 48. and 72.hours), 500 µL of sample was taken from the medium and replaced by the same volume of fresh medium. The cumulative percentage of drug released for each time point was calculated as a percentage of the total drug incorporated into the nanocapsules.
Stability of NCs in simulated gastrointestinal fluids (SGF &SIF)
It is also necessary to determine the physical stability of drug loaded nanocapsules (SIF) pH 6.8 for 6 hours. These pH dependent stability studies were carried out in the following media by measuring the mean particle size, polydispersity index and zeta potential values of nanoparticles. SIF was prepared by dissolving 680.5 mg monobasic potassium phosphate (KH 2 PO 4 ) in 100 mL deionized water. 89.6 mg of
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NaOH was added to adjust the pH of the media. SGF without enzyme was prepared by dissolving 100 mg of NaCI in 50 mL deionized water containing 0.35 mL concentrated HCl. For each formulation; 1 mL of nanoparticle dispersion was added to 9 mL of simulated media and incubated in for 2 hours for SGF and for 6 hours for SIF. Mean particle size, PDI and zeta potential values were measured before and after incubation.
Cytotoxicity of blank CD NCs against L929 cell line
The cytotoxicity of blank CD nanocapsules was determined on mouse fibroblast cells with MTT assay. L929 (American Type Culture Collection, USA) was cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS), penicillin (50 units/mL) and streptomycin (50 µg/mL) in 25 cm 2 culture flasks.
L929 fibroblast cells were seeded at a density of 5x10 3 cells/well in 100µl DMEM.
The cultures were incubated at 37 °C in an incubator humidified with 5% CO 2 .
(Humidified CO 2 is used to prevent the cell from drying by mimicking the physiological conditions.) After 24 hours cell culture medium was replaced with fresh 
In vitro transport studies across Caco-2 cell line
In vitro transport studies were carried out across the human adenocarcinoma Caco-2 cell line, which is a widely used model for intestinal drug absorption and mimic the gastrointestinal barrier for oral chemotherapy in the recent years. where dQ/dt is the permeability rate, Co is the initial concentration on the apical side and A is the surface area of the monolayer.
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Statistical analysis
The results were expressed as mean ± SD. The significance of differences was estimated by Student's t-test. P value less than 0.05 (P < 0.05) was considered to indicate a statistically significant difference.
